Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA.
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S216-25. doi: 10.1016/j.jaci.2009.07.002. Epub 2009 Nov 24.
Vasculitis is defined by the presence of blood vessel inflammation. It can be observed in a wide variety of settings, which can be broadly grouped as secondary vasculitides, which occur in association with an underlying disease or trigger, or primary vasculitides, in which vasculitis is occurring for as-yet unknown causes. The primary systemic vasculitides comprise a range of disease entities that are uniquely identified by their clinical, histopathologic, and therapeutic characteristics. Individual diseases predominantly affect blood vessels of a particular size, which influences their clinical manifestations and has been used in their classification. The vasculitides can also differ in their severity, extending from self-limited illnesses to those that can be life-threatening in the absence of prompt initiation of treatment. Immunosuppressive agents are used to treat many vasculitic diseases. Although such approaches can be effective, the patient's long-term course can be influenced by organ damage from their initial presentation, disease relapses, and medication toxicity. Recent investigations have focused on understanding disease pathophysiology and the exploration of novel therapeutic approaches.
血管炎的定义是血管炎症的存在。它可以在多种情况下观察到,可以广泛地分为继发性血管炎,其发生与潜在疾病或诱因相关,或原发性血管炎,其发生的原因尚不清楚。原发性系统性血管炎包括一系列疾病实体,它们通过其临床、组织病理学和治疗特征来独特识别。个别疾病主要影响特定大小的血管,这影响其临床表现,并已用于其分类。血管炎的严重程度也不同,从自限性疾病到那些如果不及时开始治疗可能危及生命的疾病。免疫抑制剂用于治疗许多血管炎疾病。尽管这些方法可能有效,但患者的长期病程可能受到其初始表现、疾病复发和药物毒性引起的器官损伤的影响。最近的研究集中在理解疾病的病理生理学和探索新的治疗方法上。